login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANI PHARMACEUTICALS INC (ANIP) Stock News
USA
- NASDAQ:ANIP -
US00182C1036
-
Common Stock
80.035
USD
-1.03 (-1.28%)
Last: 11/19/2025, 2:15:21 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ANIP Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) Reports Record Q3 2025 Earnings, Beating Estimates
5 hours ago - By: Zacks Investment Research
ANI (ANIP) Loses 15% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
a day ago - By: Zacks Investment Research
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
a day ago - By: Zacks Investment Research
ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know
2 days ago - By: Zacks Investment Research
- Mentions:
MOH
IDXX
EXAS
Molina Secures Deal From AHCA to Serve Florida's Medicaid Members
5 days ago - By: Zacks Investment Research
- Mentions:
TEVA
AMRX
VTRS
ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell?
5 days ago - By: Zacks Investment Research
- Mentions:
ADMA
KOD
ARQT
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
6 days ago - By: Zacks Investment Research
- Mentions:
NVS
ADMA
ARQT
Novartis' Phase III Malaria Study Meets Key Non-Inferiority Endpoint
7 days ago - By: Zacks Investment Research
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
7 days ago - By: Zacks Investment Research
- Mentions:
BDTX
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
8 days ago - By: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London
8 days ago - By: Zacks Investment Research
- Mentions:
ADMA
EDIT
ARQT
Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y
9 days ago - By: The Motley Fool
- Mentions:
TBBK
KTOS
STRL
BWXT
...
The Bancorp: Building the Pulse of Digital Finance One Partnership at a Time
12 days ago - By: Zacks Investment Research
- Mentions:
ALKS
CRMD
IOVA
IOVA Soars 28% on Narrower-Than-Expected Loss in Q3, Revenues Up Y/Y
12 days ago - By: Zacks Investment Research
- Mentions:
SNY
NVAX
ARQT
Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised
12 days ago - By: Zacks Investment Research
- Mentions:
RDY
ESPR
ARQT
ESPR's Q3 Earnings Lag Estimates, Revenues Rise Y/Y, Stock Down
12 days ago - By: Zacks Investment Research
- Mentions:
ALLO
ALKS
CRMD
Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales
12 days ago - By: Zacks Investment Research
- Mentions:
PBYI
SNDX
ARQT
PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised
12 days ago - By: Zacks Investment Research
- Mentions:
LLY
NKTR
ACAD
Nektar Therapeutics Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
12 days ago - By: Zacks Investment Research
- Mentions:
REGN
ACAD
NTLA
Intellia Q3 Loss Narrower Than Expected, Stock Down on Pipeline Trouble
12 days ago - By: Zacks Investment Research
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics
12 days ago - By: Zacks Investment Research
- Mentions:
MXCT
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates
12 days ago - By: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
12 days ago - By: Benzinga
- Mentions:
WEN
FLGT
CNH
CTEV
...
Earnings Scheduled For November 7, 2025
13 days ago - By: Zacks Investment Research
- Mentions:
ALKS
CRMD
RVMD
Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil
13 days ago - By: Zacks Investment Research
- Mentions:
ACAD
SNDX
ARQT
ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
13 days ago - By: Zacks Investment Research
- Mentions:
TEVA
SNDX
ARQT
TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock Up
13 days ago - By: Zacks Investment Research
- Mentions:
ALKS
JAZZ
CRMD
JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales View
13 days ago - By: Zacks Investment Research
- Mentions:
FOLD
CPRX
ACAD
Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y
13 days ago - By: Benzinga
Examining the Future: ANI Pharmaceuticals's Earnings Outlook
14 days ago - By: Zacks Investment Research
- Mentions:
CYTK
Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
14 days ago - By: Zacks Investment Research
- Mentions:
ALKS
PRGO
CRMD
Perrigo Q3 Earnings Beat, Sales Miss, Stock Falls on '25 View Cut
Please enable JavaScript to continue using this application.